From the Blog

The WBE blog offers detailed insights, updates and commentary on current events related to class action and multidistrict lawsuits for consumers, businesses and investors. If there is a topic you would like to see covered in a future blog, contact us to let us know.

Featured Blog

No results found.
No results found.

Proposed FDA Rule Allows Generic Drug Manufacturers to Update Labeling

By WBE | 11.13.2013 | For Consumers, You Should Know
After much anticipation, the U.S. Food and Drug Administration (FDA) has taken action to place responsibility on generic drug manufacturers to provide adequate warnings to consumers, and hold ...
Read more

Sixth Circuit Reviews Classwide Arbitration

By WBE | 11.11.2013 | For Consumers, You Should Know
In Reed Elsevier, Inc. v. Crockett, Case No. 12-3574, the United States Court of Appeals for the Sixth Circuit struck yet another blow to consumers whose contracts of adhesion force arbitration ...
Read more

JP Morgan Chase Expected to Pay Record Settlement

By WBE | 10.24.2013 | For Consumers, Hall Of Shame, In The News, Villain Of The Week, You Should Know
The story of banking giant JP Morgan Chase’s $13 billion settlement has been in heavy rotation on network and cable news outlets this week, as it should be. This settlement is the largest ever ...
Read more

A Proposed Change to the Federal Rules of Civil Procedure: Addressing Spoliation of Evidence

By WBE | 9.11.2013 | You Should Know
The problem is familiar: a party fails to preserve some document or thing that would have been discoverable under the Rules, and possible evidence is lost. Years ago, these spoliation of ...
Read more

A Hero

By WBE | 8.27.2013 | The Firm, You Should Know
I just finished a book about our profession at its very best. The book is Devil in the Grove, by Gilbert King.  A 2013 Pulitzer Prize winner for Non-Fiction, Devil in the Grove tells the story ...
Read more

Supreme Court Makes Second Landmark Ruling on the Liability of Generic Drug Manufacturers

By WBE | 8.19.2013 | In The News
Over the last year, I have written about the evolving law on an issue at the center of much controversy: the ability to bring product liability lawsuits against generic drug manufacturers.  ...
Read more
No results found.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Receive News Updates

Get the latest from Wexler Wallace LLP & stay informed.